secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-032137
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amneal shareholders approve all proposals at 2026 annual meeting
----------------------------------------------------------------

- All 10 director nominees elected; Chintu Patel received ~270.4M votes (highest).
- Advisory say-on-pay passed with ~96.5% support (269.1M for, 2.58M against).
- Ernst & Young LLP ratified as auditor for fiscal 2026 with 293.2M votes for.
- Broker non-votes on director election and say-on-pay totaled 21.95M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000162828026032137/0001628280-26-032137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000162828026032137/amrx-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-032137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer